ALLGENESIS BIOTHERAPEUTICS INC.
Update：2025/12/24
Industries
Main Industry
Biotechnology
Main Product/Service
Allgenesis focuses on developing innovative ophthalmic therapies targeting both retinal and anterior segment diseases. Its pipeline includes AG-73305, a dual-action anti-VEGF and disintegrin molecule for diabetic macular edema and age-related macular dege
Founded Year
2014
Unified Business No.
54681545
Status
Active
Number of Employees
0
Total Paid-in
Capital
912,600,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Allgenesis is a privately owned, clinical stage, biopharmaceutical company situated in Taipei City, Taiwan.We strive to find solutions for major diseases of the eye affecting the vision of millions of people worldwide.Our mission is to establish a world-r
